| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.14 | 0.004 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.15 | 0.007 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.14 | 0.008 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.17 | 0.008 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.095 | 0.08 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.092 | 0.09 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.094 | 0.1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.086 | 0.2 |